Vision Disorder Clinical Trials

7 recruitingLast updated: May 21, 2026

There are 7 actively recruiting vision disorder clinical trials across 11 countries. Studies span Phase 3, Early Phase 1, Not Applicable, Phase 2. Top locations include Nijmegen, Netherlands, Miami, Florida, United States, Ghent, Belgium. Updated daily from ClinicalTrials.gov.


Vision Disorder Trials at a Glance

7 actively recruiting trials for vision disorder are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Phase 3 with 2 trials, with the heaviest enrollment activity in Nijmegen, Miami, and Ghent. Lead sponsors running vision disorder studies include Laboratoires Thea, Eye & ENT Hospital of Fudan University, and Ocuphire Pharma, Inc..

Browse vision disorder trials by phase

About Vision Disorder Clinical Trials

Looking for clinical trials for Vision Disorder? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Vision Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Vision Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 2

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

deaf-blindRetinitis pigmentosa (RP)Retinal Disease+4 more
Laboratoires Thea81 enrolled27 locationsNCT06627179
Recruiting
Phase 3

Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)

Sensation DisordersLeber Congenital AmaurosisRetinal Disease+7 more
Laboratoires Thea32 enrolled14 locationsNCT06891443
Recruiting
Not Applicable

Viewing Strategy Training in Children With (Cerebral) Visual Impairment

Vision, LowVision Disorders
Royal Dutch Visio60 enrolled1 locationNCT05600140
Recruiting

Natural History Study of Inherited Retinal Diseases

MutationMacular DegenerationRetinal Dystrophies+7 more
Zhongmou Therapeutics200 enrolled1 locationNCT07085533
Recruiting
Phase 3

OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity

Vision Loss NightVision Disorders
Ocuphire Pharma, Inc.200 enrolled23 locationsNCT07140783
Recruiting

Zhejiang Adolescent Spine and Vision Health Cohort: A Longitudinal Database Analysis

MyopiaVision DisordersScoliosis Idiopathic
Second Affiliated Hospital of Wenzhou Medical University73,000 enrolled1 locationNCT06992622
Recruiting
Early Phase 1

Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis

Bacterial KeratitisSensation DisordersInfections, Bacterial+7 more
Eye & ENT Hospital of Fudan University20 enrolled1 locationNCT06451172